We are live on ! Find out more

Tenon Medical

TNON

Market cap $2.48M

3.72 USD

-0.05

1.33%

At close Updated Sep 4, 4:00 PM EDT

1 day

-1.33%

5 days

-18.78%

1 month

-44.81%

3 months

-83.27%

6 months

-86.24%

Year to date

-89.09%

1 year

-90.76%

5 years

-99.99%

10 years

-99.99%

About: Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Employees: 26

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 6.3%

Neutral 93.8%

Negative 0%

WallachBeth Capital Announces Closing of Tenon Medical

$3M Private Placement Offering JERSEY CITY, N.J., Aug. 31, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders closed its previously announced private placement pursuant to securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering.

WallachBeth Capital Announces Closing of Tenon Medical

Tenon Medical Announces Closing of $3M Private Placement Offering

LOS GATOS, CA / ACCESS Newswire / August 31, 2026 / Tenon Medical, Inc. (Nasdaq:TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, has closed its previously announced private placement pursuant to securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering. The combined effective offering price for each share of common stock and accompanying warrants to be issued is $5.02.

Tenon Medical Announces Closing of $3M Private Placement Offering

Tenon Medical Stock Climbs Friday: What's Going On?

Shares of Tenon Medical Inc. (NASDAQ:TNON) are rising Friday morning as investors react to a newly announced institutional private placement financing coupled with strong fundamental momentum from its recent second-quarter operational updates.

Tenon Medical Stock Climbs Friday: What's Going On?

WallachBeth Capital Announces Tenon Medical Pricing of $3M Private Placement Offering

JERSEY CITY, N.J., Aug. 28, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that on August 27, 2026, Tenon Medical, Inc. (Nasdaq: TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has entered into a securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering.

WallachBeth Capital Announces Tenon Medical Pricing of $3M Private Placement Offering

Tenon Medical Announces Pricing of $3M Private Placement Offering

LOS GATOS, CA / ACCESS Newswire / August 28, 2026 / Tenon Medical, Inc. (NASDAQ:TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that on August 27, 2026 it has entered into a securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering. The combined effective offering price for each share of common stock and accompanying warrants to be issued is $5.02.

Tenon Medical Announces Pricing of $3M Private Placement Offering

Tenon Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

LOS GATOS, CA / ACCESS Newswire / August 24, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). On February 25, 2026, the Company received a letter from the Listing Qualifications staff of Nasdaq (the "Staff") notifying it that, for the prior 30 consecutive business days, the closing bid price of the Company's common stock had been below the $1.00 per share minimum required under the Bid Price Rule.

Tenon Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tenon Medical, Inc. (TNON) Q2 2026 Earnings Call Transcript

Tenon Medical, Inc. (TNON) Q2 2026 Earnings Call Transcript

Tenon Medical, Inc. (TNON) Q2 2026 Earnings Call Transcript

Tenon Medical Reports Second Quarter 2026 Financial Results

~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~ ~ Second Quarter Gross Profit of $0.8 Million, a 232% Increase Compared to Prior Year; Gross Margin of 64% ~ ~ Received FDA 510(k) Clearance for Updated Catamaran® SI Joint Fusion System ~ ~ Physician and Distributor Training Events Increased 98% in 1H 2026 Compared to 2H 2025, Supporting Record Monthly Case Volume in July 2026 ~ ~ Closed $4.2 Million Public Offering Subsequent to Quarter End ~ LOS GATOS, CA / ACCESS Newswire / August 13, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today reported financial results for the second quarter ended June 30, 2026. Financial Results and Business Updates Second Quarter 2026 Results: Second quarter revenue of $1.3 million, an increase of 127% compared to $0.6 million in the second quarter of 2025.

Tenon Medical Reports Second Quarter 2026 Financial Results

Tenon Medical, Inc. Announces 1:35 Reverse Stock Split

LOS GATOS, CA / ACCESS Newswire / August 6, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced a 1-for-35 reverse stock split of the Company's issued and outstanding common stock. The reverse stock split will become effective at 12:01, Eastern Time, on August 10, 2026, prior to the commencement of trading on the Nasdaq Capital Market.

Tenon Medical, Inc. Announces 1:35 Reverse Stock Split

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m.

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

See News Rankings

Price charts implemented using Lightweight Charts™